You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Belarus

Apr 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

High value growth due to currency crisis

2011 was difficult for Belarus as a second, stronger currency crisis affected the country. The prices for medicines doubled due to the national currency devaluation of 42% on 24 May 2011, as well as the ongoing currency devaluation. Consumer health had value growth in 2011, driven by the vast increase in unit prices. Several measures were taken by the authorities in 2011 to minimise the increase in the prices of consumer health products. The main measure was to classify imported medicines as goods of critical import. This allowed the purchase of foreign currency to buy the medicines at the rate of the National Bank of Belarus, which was lower than the market exchange rate with Belarusian roubles by 20-80% depending on the month of the year. Other measures included the widening of the range of locally-produced products (whose prices are regulated by the Ministry of Economics) and the signing in May 2010 of The Memorandum of Price Restraints for 2010-2011 by the Ministry of Health and key pharmaceutical players, including 150 owners of chemists/pharmacies and 59 foreign companies.

Key market trend is consumption of economy products

The key trend in 2011 was the consumption of economy products. This led to an increasing volume share of budget brands, with price being the decisive factor in purchasing. Most of the consumers in Belarus were interested in cheaper generics, rather than in original, expensive products.

Crisis is an opportunity for local players

Local leading pharmaceutical manufacturers used the economic crisis as an opportunity to increase their shares at the expense of imported brands. The crisis in 2011 resulted in shortage of foreign currencies, as well as in strong devaluation of the Belarusian rouble. As a result, unit prices for medicines had high growth, which, together with decreased consumer purchasing power, helped local cheaper products to gain higher market shares. According to Belbiopharm Concern, the controlling body of local pharmaceutical manufacturers, the current value share of local medicines in the entire pharmaceutical market (retail and hospital segments) rose in the first quarter of 2011 to 26% compared to 23% in 2010.

Government regulation of pharmaceutical industry

Pharmaceutical market in Belarus is highly regulated by the state, with strong price control of manufacturing and retail sales. The main tool used by the authorities is the limiting of retail and wholesale mark-ups. Mark-ups in consumer health also depend on the manufacturer selling price (MSP). The higher the MSP, the lower mark-ups are allowed to be. The Belarusian authorities are also using administrative resources in order to increase sales of locally-produced medicines, with measures introduced in 2009-2011 including further limitations regarding state expenditure on medicines and medical equipment. The Ministry of Health obliges suppliers of medicines and medical equipment to give preference to locally-produced products, even if they are up to 15% more expensive than imported alternatives.

Ambitious plans for the future

Belarus plans to reduce dependence on imported medicines in the forecast period, which is one of the major challenges according to Belbiopharm Concern. According to a representative from this organisation, Belarus plans to manufacture 60% of the major medicines between 2011-2015, and the value share of locally-produced medicines in retail sales will have to be more than 50% by the end of the forecast period. In the forecast period the export of medicines from Belarus is planned to increase by 2.6-3 times. Goals will be achieved through the development of innovative medicines, further development of the distribution network, diversification of export structure and co-operation of domestic pharmaceutical enterprises with foreign companies. Agreements of intentions and investments are already signed with a number of foreign companies; and more are planned.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Belarus with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Belarus, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Belarus for free:

The Consumer Health in Belarus market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Belarus?
  • What are the major brands in Belarus?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Belarus - Industry Overview

EXECUTIVE SUMMARY

High value growth due to currency crisis

Key market trend is consumption of economy products

Crisis is an opportunity for local players

Government regulation of pharmaceutical industry

Ambitious plans for the future

KEY TRENDS AND DEVELOPMENTS

Strengthening of local manufacturers

Strong government involvement remains in consumer health

Customs Union as additional market opportunity

Social orientation of Belarusian healthcare system

Health and wellness trend slows down during the crisis

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Generics

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Belarus - Company Profiles

Belmedpreparaty RUP in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Belmedpreparaty RUP: Competitive Position 2011

Borisov Medical Preparations Plant OAO in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Borisov Medical Preparations Plant OAO: Competitive Position 2011

Pharmland SOOO in Consumer Health (Belarus)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Pharmland SOOO: Competitive Position 2011

Adult Mouth Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Sales in adult mouth care are seasonal. Long, cold winter seasons increase oral problems such as throat inflammation. As a result, oral sprays and liquid mouthwash remedies are increasing in popularity, especially during the cold season and amongst urban citizens concerned with their health and image. The willingness of consumers to self-medicate depends on their ailment. In the case of throat inflammation or milder conditions, consumers use OTC products or even home remedies. Self-medication is popular within adult mouth care for the treatment of mild problems. However, consumers will consult a doctor when suffering from more severe conditions such as ulcers or a high level of pain. For children, parents prefer to see a doctor for advice and to purchase higher quality and more expensive products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Since the number of brands within adult mouth care is limited, competition is weak, with ICN Pharmaceutical dominating sales in 2011 with a retail value share of 52%. ICN Pharmaceutical was also the best performing company in 2011, increasing its retail value share by one percentage point. The company’s Solcoseryl brand is well-known amongst consumers in an area where brand awareness and recognition is minimal.

PROSPECTS

  • Adult mouth care is expected to have constant value CAGR of 1% over the forecast period. Growth will be supported by increasing unit prices as a result of rising import costs due to the on-going devaluation of the local currency.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Belarus - Category Analysis

HEADLINES

TRENDS

  • The stressful and hectic lifestyle of many Belarusians, particularly urban citizens, supported the increasing demand for analgesics in 2011. Many urban citizens work longer hours building careers and earning extra money to survive in crisis conditions; which means they have less time for rest and relaxation. As a result, they suffer from stress-related pains, which support demand for analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • Dr Reddy's Laboratories Ltd led analgesics in 2011, recording a retail value share of 11%. Belmedpreparaty RUP came second with a 10% value share, followed by Nycomed Group with 9% and Bayer AG with 8%.

PROSPECTS

  • Analgesics is expected to increase by a constant value 2% CAGR during the forecast period, which is much lower than the review period CAGR. The high dependence on imports, the on-going devaluation of the local currency and the fact that consumers are switching to higher quality and less harmful analgesics will underpin value growth over the forecast period. Strong government control of the pharmaceutical industry, its efforts to restrain price growth and its support of local manufacturers and their products, which are several times cheaper than imported brands, will slow down unit prices and consequently value growth. The share of Belarusian medicines is expected to increase during the forecast period, which will also slow down value growth.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Belarus - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping had current retail value growth of 67% in 2011, with sales being fuelled by rising stress levels and longer working hours. In addition, increasing urbanisation and rising night-time noise levels in urban areas also contributed to growth. Belarusian consumers tended to self-medication in this area. Having no time to see doctors due to hectic lifestyles, consumers preferred to purchase well-promoted OTC products based on their own experience, advertising and advice from pharmacists. Meanwhile, sales of paediatric products also increased as children were increasingly left overexcited by computer games and TV. Widening product range and rising consumer product awareness fuelled growth in 2011, being supported by mass media advertising. Advertising and promotion played an important role in increasing brand awareness.

SWITCHES

COMPETITIVE LANDSCAPE

  • Ivax Corp led sales in 2011 with a retail value share of 20%. The company’s Novo-Passit brand is well known, well-advertised and highly popular amongst consumers.

PROSPECTS

  • In the forecast period demand for calming and sleeping products is expected to continue to increase due to the busier, stressful and hectic lifestyle in urban areas, as well as the ageing population in Belarus. Calming and sleeping has a forecast period constant value CAGR of 2%. Growth will also be supported by longer working hours for the majority of consumers as a result of busier lifestyle and the currency crisis – developments that will result in rising anxiety and sleep disturbance. In mild cases consumers are expected to rely on well-promoted and well-known OTC products, and will become more aware of new calming and sleeping products thanks to advertising by manufacturers.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Calming and Sleeping Company Shares 2007-2011
  • Table 26 Calming and Sleeping Brand Shares 2008-2011
  • Table 27 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 28 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Belarus - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy (hay fever) remedies products are seasonal in Belarus, with sales of cough and cold products increasing in autumn and winter, while sales of allergy products peak in late spring and summer. The performance usually depends on the severity of the winter and autumn seasons. The very cold winter season of 2011 boosted demand for cough and cold remedies. For the same reason combination products and cough remedies continued to lead sales during 2011. Due to the hectic lifestyle in Belarus, demand for OTC cough and cold remedies is increasing. Local consumers prefer OTC products to prescribed medicines as they do not like to waste time waiting to see a doctor and instead seek qualified advice from pharmacists. Belarusians are getting more aware of cough and cold products thanks to advertising from manufacturers and their own experiences in cold winter seasons. There is also a wide range of products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis AG led in sales of cough, cold and allergy (hay fever) remedies in 2011 with 11% current value share. The company benefited from the very good performance of its brand Theraflu, which was not only the leading brand in this segment, but also the leading brand overall in OTC consumer health in Belarus in both 2010 and 2011. Due to the good performance of its Theraflu brand Novartis AG also demonstrated strong increase in current retail value share in 2011 by one percentage point. The cold winter and advertising campaign also supported the company’s increasing sales.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is expected to have constant value CAGR of 2% over the forecast period. The products will always be in high demand in Belarus due to the country’s harsh climatic conditions and cold and wet winter seasons. However, growth is difficult to estimate as outbreaks of flu have a major impact on sales, and these outbreaks vary from year to year. Combination products and cough remedies will remain the largest product areas over the forecast period, with products being widely used to reduce symptoms and enable consumers to continue working while suffering from cold or flu symptoms. Consumers are expected to become more conscious in choosing effective, but safe treatment. They will also show more trust in preventive treatments, such as vitamins and dietary supplements and antiviral remedies as a good way to avoid sick leave.

CATEGORY DATA

  • Table 29 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 32 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 34 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Belarus - Category Analysis

HEADLINES

TRENDS

  • In 2011 economic situation in Belarus was difficult, which for many Belarusians resulted in longer working hours and higher stress levels. Many consumers, particular in urban areas, did not have enough time to prepare balanced and nutritious meals and ate on-the-go instead. Also, in urban areas, the popular slimming diets were the cause of various digestive disorders. In addition, smoking, alcohol consumption, and rising stress levels for urban residents all contributed to increasing demand for digestive products. In rural areas consumers often suffered the negative consequences of poor hygiene and high fat diets. Consumers in rural areas also consumed alcoholic drinks and cigarettes, which was their way to cope with stressful situations. The fact that the population in Belarus is ageing also helped to boost demand for digestive remedies. These factors resulted in an increasing number of different digestive disorders, such as indigestion, diarrhoea, heartburn and constipation. As a result, demand for digestive remedies in the country remained strong, with value growth of 67% in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie AG led the sales in digestive remedies in 2011, recording a retail value share of 10% thanks to its brand of digestive enzymes Mezym. The brand enjoys a high level of popularity among urban citizens in 2011 and is supported by advertising campaigns. The company had a slight decrease in sales in 2011. Its brand Mezym Forte was more expensive than its closest rival in digestive enzymes, namely Festal by Sanofi-Aventis, as well as local brand Pancreatin by Belmedpreparaty RUP. Price sensitive consumers were trading down in crisis conditions, choosing cheaper products and brands. Sanofi-Aventis was ranked second with a 9% share in retail value sales, followed by Bayer AG with 6%.

PROSPECTS

  • Sales of digestive remedies are expected to increase by a constant value CAGR of 1% due to ongoing changes in lifestyle in Belarus. The high incidence of digestive ailments in Belarus due to the traditionally high-fat diet in the country will fuel growth. Hectic and stressful lifestyles, longer working hours, absence of time for cooking nutritious meals, on-the-go consumption, increase in the popularity of fast-food, pollution, and consumption of alcoholic drinks and cigarettes will support growth. Population ageing and age-related digestive disorders will also add to growth.

CATEGORY DATA

  • Table 35 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 36 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 37 Digestive Remedies Company Shares 2007-2011
  • Table 38 Digestive Remedies Brand Shares 2008-2011
  • Table 39 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Ear care had current retail value growth of 68% in 2011, with sales reaching BYR2.4 billion. As in eye care, consumers suffering from ear ailments typically preferred to seek advice from a doctor instead of self-medicating, with doctors often recommending more expensive but more effective remedies with fewer side effects. The fact that consumers typically use Rx medication to treat ear care problems hampered the potential growth for OTC ear care. The majority of consumers of ear care products are children. Parents in Belarus prefer not to see the doctor and to purchase recommended-by-a-doctor product, even if it is more expensive, which also helped to increase sales. OTC ear care also remained small due to the strong competition from ear care Rx medicines.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi-Aventis led sales in 2011 with a value share of 23%, followed by ICN Pharmaceutical with 18% and Bayer AG with 10%. In general, brand awareness was low, with numerous local unbranded products being popular among elderly consumers, particularly in rural areas.

PROSPECTS

  • Ear care has a projected forecast period constant value CAGR of 1%. Growth over the forecast period will be restricted by strong competition from ear Rx medicines, as many consumers will continue to seek professional help when suffering from ear problems. Most Belarusian consumers will still consider ear problems as too complicated to self-medicate.

CATEGORY DATA

  • Table 41 Sales of Ear Care: Value 2006-2011
  • Table 42 Sales of Ear Care: % Value Growth 2006-2011
  • Table 43 Ear Care Company Shares 2007-2011
  • Table 44 Ear Care Brand Shares 2008-2011
  • Table 45 Forecast Sales of Ear Care: Value 2011-2016
  • Table 46 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Belarus - Category Analysis

TRENDS

  • A large number of 28-day pack hormonal contraceptive medicines are available in Belarus. However, most consumers in Belarus still believe that hormonal contraceptives, if used frequently, cause side effects, and should only be used under medical supervision. Most of the hormonal contraceptive medicines in Belarus are Rx products.

CATEGORY DATA

  • Table 47 Sales of Emergency Contraception: Value 2006-2010
  • Table 48 Sales of Emergency Contraception: % Value Growth 2006-2010

Eye Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Eye care in 2011 benefited from an increasing number of Belarusians suffering from dry eye syndrome, tired eyes and allergy problems. One of the main reasons behind eye problems is increasing usage of computers, both in offices and at home. Other reasons are the ageing population in Belarus, rising levels of pollution, increasing popularity of wearing contact lenses and air conditioners in offices.

SWITCHES

COMPETITIVE LANDSCAPE

  • The number of brands and players within eye care in 2011 was limited. Consumers are not willing to self-medicate in this area, with most people preferring to seek professional advice before treatment. Relatively easy access to ophthalmologists enables many people suffering from eye problems to receive expert advice and, frequently, a prescription for treatment. This is why there are more Rx brands than OTC products in eye care. The leading companies in 2011 were Alcon Universal SA with 19% value share, followed by Santen Pharmaceutical with 14%.

PROSPECTS

  • Eye care has a projected forecast period constant retail value CAGR of 2%. Growth will mainly be fuelled by rising demand for products due to the ageing population, increasing pollution, longer working hours in front of computer screens, and increasing popularity of contact lenses.

CATEGORY DATA

  • Table 49 Sales of Eye Care by Category: Value 2006-2011
  • Table 50 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 51 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 52 Standard Eye Care by Positioning 2007-2011
  • Table 53 Eye Care Company Shares 2007-2011
  • Table 54 Eye Care Brand Shares 2008-2011
  • Table 55 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 56 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Belarus - Category Analysis

HEADLINES

TRENDS

  • The key trend in herbal/traditional in 2011 was growing consumer trust in the products, especially because such products were cheaper than synthetic medicines. In 2011 herbal/traditional products had current value growth of 68%, with sales fuelled by the health and wellness trend, as well as increasing health-consciousness amongst Belarusian consumers. In the review period Belarusians paid more attention to the safety of pharmaceutical goods, giving priority to herbal/traditional products as they have fewer or no side-effects compared to standard medicines.

COMPETITIVE LANDSCAPE

  • Herbal/traditional products was fragmented with unbranded products and herbs mixes from local manufacturers. There were three leading companies: Unique Pharmaceutical Laboratories with 8% value share; Novartis AG with 7% and Teva Pharmaceutical Industries Ltd with 7%. This was due to the good performance of the companies' well-known brands Doktor Mom (Unique Pharmaceutical Laboratories), Novo-Passit (Teva Pharmaceutical Industries), Plantex (Novartis) and Persen (Novartis).

PROSPECTS

  • Herbal/traditional products is expected to have a constant value CAGR of 2% over the forecast period, with herbal/traditional cough, cold and allergy (hay fever) products, herbal/traditional calming and sleeping products and herbal/traditional vitamins and dietary supplements supporting growth. Increasing awareness of the importance of leading a healthy lifestyle will continue to increase demand for herbal/traditional products in Belarus. These products are considered to be healthier alternatives to chemical-based medicines, with fewer or no side effects, and are very important to key consumer groups of children, elderly people and rural consumers. Rising consumer health concerns and the traditional conservatism of people in Belarus will increase demand for herbal/traditional products over the forecast period.

CATEGORY DATA

  • Table 57 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 58 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 59 Herbal/Traditional Products Company Shares 2007-2011
  • Table 60 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 61 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 62 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • A number of product areas in medicated skin care are still associated with embarrassment among Belarusian consumers. In addition, rising self-medication trend supported growth. The fact that many consumers view skin ailments as being embarrassing means that they often prefer to purchase well-promoted OTC products based on their own experience, advertising and advice from pharmacists. Rising urban population and stress levels in Belarus also resulted in an increase in the incidence of skin problems. As a result, the majority of consumers of medicated skin care products in Belarus are urban citizens of all ages. A widening product range and increasing consumer product awareness fuelled growth in 2011, supported by mass media advertising. Advertising and promotion played an important role in educating consumers in Belarus, particularly in such skin problems as vaginal or skin fungal infections, haemorrhoids or cold sores, when consumers are reluctant to ask for friends’ or even pharmacists’ advice and opt for self-medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Richter Gedeon led sales in 2011 with a retail value share of 10%. The company offers successful brands within the fragmented medicated skin care in Belarus. For example, Terbisil had 30% value share of topical antifungals and Gynofort had 31% value share of vaginal antifungals. These brands enjoy a high level of recognition amongst consumers in Belarus.

PROSPECTS

  • Medicated skin care in Belarus is expected to grow by a constant value CAGR of 2% in the forecast period, supported by growing consumer awareness of skin disorders, as well as the reduction in the taboos about skin problems. Poor nutrition, pollution and the increasing incidence of sexually transmitted diseases, along with the growing number of allergies, will increase demand for medicated skin care products in Belarus over the forecast period. The fact that some areas remain underdeveloped and that there is only a limited number of brands available means that there is still significant scope for growth.

CATEGORY DATA

  • Table 63 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 64 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 65 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 66 Medicated Skin Care Brand Shares 2008-2011
  • Table 67 Hair Loss Treatments Brand Shares 2008-2011
  • Table 68 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 69 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Belarus - Category Analysis

HEADLINES

TRENDS

  • Cigarette volume sales in Belarus reached 29.7 billion sticks in 2011, an increase from 25.5 billion sticks in 2010. Whilst the number of male smokers decreased insignificantly in 2011. Totally over two million people in the country continue to smoke. However, the number of deaths from smoking-related illnesses per 100,000 inhabitants is growing despite government efforts to lower the smoking rate. Heart disease accounts for some 88% of deaths from smoking-related illnesses in Belarus. Other smoking-related illnesses include diseases of the respiratory system and lung cancer.

SWITCHES

COMPETITIVE LANDSCAPE

  • NRT smoking cessation aids were only introduced in 2001 and continue to suffer from a lack of competition in 2011 with the number of brands limited to Nicorette in NRT gum and Tabex in herbal/traditional smoking cessation aids. The success of these two brands was due to the absence of real competition.

PROSPECTS

  • NRT smoking cessation aids is expected to have a constant value CAGR of 1% over the forecast period. Growth will be very slow due to the very limited product choice and strong competition from alternative methods to quit smoking and products. On the other hand, the relatively large smoking population in Belarus, narrow product range and absence of real competition could attract new players over the forecast period. The fact that a growing number of Belarusians now recognise the harmful effects of smoking will support the growth in the segment and improve the situation within NRT smoking cessation aids over the forecast period.

CATEGORY INDICATORS

  • Table 70 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 71 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 72 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 73 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 74 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 75 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 76 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 77 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Belarus - Category Analysis

HEADLINES

TRENDS

  • Demand for sports nutrition products remained limited to sportsmen and professional sport trainers in 2011, with the majority of consumers in Belarus remaining unaware of such products.

COMPETITIVE LANDSCAPE

  • In 2011, the following companies had sports nutrition brands: Universal Nutrition, Dymatize Enterprises, Maxler and Optimum Nutrition. The first two companies had the highest value shares: Universal Nutrition Inc with 13% and Dymatize Inc with 12%.

PROSPECTS

  • Sports nutrition is unlikely to change over the forecast period as demand for products will remain limited to sportsmen, professional sport trainers and experienced gym goers, with awareness of such products amongst the majority of the population expected to remain very low. The fact that only imported brands are available means that products will remain too expensive for the majority of consumers in the country.

CATEGORY DATA

  • Table 78 Sales of Sports Nutrition: Value 2006-2011
  • Table 79 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 80 Sports Nutrition Company Shares 2007-2011
  • Table 81 Sports Nutrition Brand Shares 2008-2011
  • Table 82 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 83 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Belarus - Category Analysis

HEADLINES

TRENDS

  • Value growth was high in 2011 was high at 68%. This was due to the vast increases in unit prices for the products, caused by sharp currency devaluation. Growth was supported by the healthy lifestyle trend. However, this trend was limited to urban areas since most consumers in rural areas had low awareness of the benefits of the consumption of vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Competition in 2011 was strong within vitamins and dietary supplements, with Bayer AG leading sales with a retail value share of 14%, followed by Nycomed Group with 9%. Novartis AG and Ferrosan A/S each had 8% value share in 2011. Four companies had 5% shares each - Akvion ZAO, Ekzon RUP, Minskintercaps SP and Malkut ZAO, among which the latter three are local companies.

PROSPECTS

  • Vitamins and dietary supplements is expected to have a constant value CAGR of 1% over the forecast period. The trend for healthy lifestyle will drive the demand for vitamins and dietary supplements, with growing focus on health and personal appearance. Consumer awareness about the necessity of consumption of vitamins and dietary supplement as a preventive measure will increase in the forecast period.

CATEGORY DATA

  • Summary 12 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 84 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 85 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 86 Dietary Supplements by Positioning 2007-2011
  • Table 87 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 88 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 89 Vitamins Brand Shares 2008-2011
  • Table 90 Dietary Supplements Brand Shares 2008-2011
  • Table 91 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 92 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Belarus - Category Analysis

HEADLINES

TRENDS

  • Increasing health awareness and rising concerns about personal appearance continued to stimulate the sales of weight management products. Females in Belarus, particularly in urban areas, realise the impact of weight on their overall well-being, careers and personal life. Their interest in maintaining a reasonable weight was the main reason for weight management products’ popularity in 2011. Weight management products are a good alternative to obesity products, which are only available in limited numbers and are perceived as being expensive. Although Belarusians are concerned about their health and appearance, per capita sales of weight management remained low in Belarus, with the majority of the population still preferring to reduce food consumption or to go to sports clubs instead of purchasing slimming products on a regular basis.

COMPETITIVE LANDSCAPE

  • Russian company Evalar led sales in 2011 with a value share of 49%. This was due to the popularity of the company’s brands, especially Turboslim. Evalar’s products are not expensive compared to those of its competitors – a fact which is highly important given the economic conditions. In addition, the fact that the company continues to introduce new and innovative products helps to maintain consumer interest and loyalty. For example, in 2011 the company launched an improved version of its Turboslim brand, with L-carnitine and alpha-lipoid acid for speeding up the body’s metabolism to support weight loss. In addition, alpha-lipoid acid helps to reduce wrinkles and lines and to reduce pigmented spots.

PROSPECTS

  • Weight management is expected to have constant value CAGR of 2% over the forecast period. Growth will be driven by more Belarusians paying attention to their personal appearance and weight. Healthy living standards will continue to be widely promoted via the mass media.

CATEGORY DATA

  • Table 93 Sales of Weight Management by Category: Value 2006-2011
  • Table 94 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 95 Weight Management Company Shares 2007-2011
  • Table 96 Weight Management Brand Shares 2008-2011
  • Table 97 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 98 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Belarus - Category Analysis

HEADLINES

TRENDS

  • Wound care had current value growth of 57% in 2011. While sales were driven by rising demand for more convenient products during the review period, in 2011 the trend for economical consumption prevailed. While unit prices for more convenient products of sticking plasters/adhesive bandages doubled in the first half of 2011, consumers in Belarus were switching to cheaper gauze, tape and other wound care.

COMPETITIVE LANDSCAPE

  • Russian company Veropharm ZAO led sales in 2011 with a retail value share of 13%, followed by Gigrovata-Saint-Petersburg ZAO and Evers-Pharm OOO each with 8%. Veropharm mainly competes within sticking plasters, which is growing in value terms more rapidly than gauze, tape and other wound care. The company’s Veropharm brand is cheaper than other sticking plaster brands, which supports its leadership.

PROSPECTS

  • Wound care is expected to grow by a constant value CAGR of 1%. Growth will be driven by unit price increases, particular if currency devaluation continues. Less price sensitive consumers will still want more expensive, more convenient value-added products. Wound care might experience wider polarisation in unit prices, with elderly consumers, consumers in rural areas and price sensitive consumers seeking simple and cheap gauze and tapes products, while high income consumers opt for value-added sticking plasters.

CATEGORY DATA

  • Table 99 Sales of Wound Care by Category: Value 2006-2011
  • Table 100 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 101 Wound Care Company Shares 2007-2011
  • Table 102 Wound Care Brand Shares 2008-2011
  • Table 103 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 104 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!